Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type I Neurofibromatosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01222728
What this trial is testing

Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients

Who this might be right for
NeoplasmsNervous System DiseaseVestibular Disease
National Institute of Neurological Disorders and Stroke (NINDS) 5
Not applicableEnrolling By InvitationNCT05238909
What this trial is testing

Developing Biomarkers of Plexiform Tumor Burden in Patients With Neurofibromatosis-Type 1

Who this might be right for
Neurofibromatosis 1NF1Neurofibromatosis Type 1
Ann & Robert H Lurie Children's Hospital of Chicago 200
Not applicableStudy completedNCT00508235
What this trial is testing

Quality of Friendships in Children With Neurofibromatosis

Who this might be right for
Neurofibromatosis
M.D. Anderson Cancer Center 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT03190915
What this trial is testing

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

Who this might be right for
Juvenile Myelomonocytic LeukemiaNeurofibromatosis Type 1
National Cancer Institute (NCI) 10
Early research (Phase 1)Study completedNCT05438290
What this trial is testing

DPCP to Treat Cutaneous Neurofibromas Associated With NF1

Who this might be right for
Cutaneous Neurofibroma
Nicholas Gulati 17
Not applicableActive Not RecruitingNCT05677594
What this trial is testing

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)Atypical Neurofibroma
Johns Hopkins University 80
Testing effectiveness (Phase 2)Ended earlyNCT00326872
What this trial is testing

AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaSpinal Cord Neurofibroma
National Cancer Institute (NCI) 26
Early research (Phase 1)Looking for participantsNCT06502171
What this trial is testing

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibroma
Girish Dhall, MD 30
Not applicableActive Not RecruitingNCT04759781
What this trial is testing

MElanoma Research Lymph Node Prediction Implementation National_001

Who this might be right for
Melanoma
SkylineDx 1,820
Not applicableLooking for participantsNCT02544022
What this trial is testing

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

Who this might be right for
Neurofibromatosis 1Plexiform Neurofibromas
National Cancer Institute (NCI) 476
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07743554
What this trial is testing

Combination of Avutometinib and Defactinib for Treatment of Relapsed, Refractory, Metastatic, or Unresectable Malignant Peripheral Nerve Sheath Tumor

Who this might be right for
MPNST (Malignant Peripheral Nerve Sheath Tumor)
Girish Dhall, MD 23
Testing effectiveness (Phase 2)Ended earlyNCT00911248
What this trial is testing

PTC299 for Treatment of Neurofibromatosis Type 2

Who this might be right for
Neurofibromatosis 2
PTC Therapeutics 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT03079999
What this trial is testing

Study of Aspirin in Patients With Vestibular Schwannoma

Who this might be right for
Vestibular SchwannomaAcoustic NeuromaNeurofibromatosis 2
Massachusetts Eye and Ear Infirmary 97
Testing effectiveness (Phase 2)Study completedNCT04481035
What this trial is testing

Antioxidant Therapy With N-acetylcysteine for Learning and Motor Behavior in Children With Neurofibromatosis Type 1

Who this might be right for
Neurofibromatosis 1
Children's Hospital Medical Center, Cincinnati 5
Testing effectiveness (Phase 2)Ended earlyNCT04085159
What this trial is testing

Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis

Who this might be right for
Cancer
Shenzhen Geno-Immune Medical Institute 100
Large-scale testing (Phase 3)Ended earlyNCT00427583
What this trial is testing

Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors

Who this might be right for
Malignant Peripheral Nerve Sheath Tumors
Novartis Pharmaceuticals 11
Not applicableLooking for participantsNCT05489783
What this trial is testing

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

Who this might be right for
Glioma
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT01125046
What this trial is testing

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

Who this might be right for
Acoustic SchwannomaAdult Anaplastic MeningiomaAdult Ependymoma+7 more
Northwestern University 50
Testing effectiveness (Phase 2)Study completedNCT03326388
What this trial is testing

Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours

Who this might be right for
Neurofibromatosis Type 1Plexiform NeurofibromaOptic Nerve Glioma
Great Ormond Street Hospital for Children NHS Foundation Trust 14
Not applicableActive Not RecruitingNCT00924196
What this trial is testing

Natural History Study of Patients With Neurofibromatosis Type I

Who this might be right for
Neurofibromatosis Type 1Malignant Peripheral Nerve Sheath TumorPlexiform Neurofibroma+2 more
National Cancer Institute (NCI) 259
Next Page